Literature DB >> 8372830

Edema of the nephrotic syndrome: the role of the atrial peptide system.

N Perico1, G Remuzzi.   

Abstract

The nephrotic syndrome is associated with an expanded interstitial volume and edema due to sodium and water retention. The mechanisms underlying these abnormalities have been only partially clarified. Renal hypoperfusion has been considered the key event that promotes avid sodium and water reabsorption by the kidney. Hypoperfusion results from hypovolemia, a consequence of urinary protein losses and decreased oncotic pressure. However, in some patients plasma volume is normal or even increased, suggesting that in such cases the cause of sodium and water retention might be independent of systemic events and possibly originates in the kidney. Experimental evidence is now available to support this, but the intrarenal mediator(s) that promote the abnormal salt retention are still not fully clear. Atrial natriuretic peptide (ANP), which increases sodium and water excretion, has been suspected to participate in fluid retention. This is consistent with experimental and human data of a markedly blunted natriuretic and diuretic response to systemic infusion of ANP in the nephrotic syndrome. Recent studies of the mechanisms of the blunted natriuretic and diuretic response to ANP documented an increased activity of renal sympathetic nerves, but the results are controversial. The altered response to ANP also may be related to a defect in the number and affinity of receptor-binding sites for the peptide. Evidence also is available of a possible defect at the level of intracellular cyclic guanosine monophosphate, the second messenger of ANP. The gene encoding for a cyclophilin-like protein, which is increased in sodium-retaining conditions, is upregulated in the kidneys of nephrotic rats, and the infusion of ANP further increases cyclophilin-like protein mRNA. Thus, multiple factors probably act in concert to induce edema formation in the nephrotic syndrome. In this review we specifically address the tubular insensitivity to the natriuretic and diuretic action of ANP, which could be an important initiating event and could possibly contribute to sustaining the edema.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8372830     DOI: 10.1016/s0272-6386(12)70137-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

1.  Hypoalbuminaemia and transcapillary pressures have role in nephrotic syndrome.

Authors:  N E Moghal
Journal:  BMJ       Date:  1999-09-25

2.  Changes of atrial natriuretic Peptide system in rats with puromycin aminonucleoside-induced nephrotic syndrome.

Authors:  Eun Hui Bae; Jongun Lee; Seong Kwon Ma; Soo Wan Kim
Journal:  Korean J Physiol Pharmacol       Date:  2009-02-28       Impact factor: 2.016

3.  Localization of corin and atrial natriuretic peptide expression in human renal segments.

Authors:  Liang Dong; Hao Wang; Ningzheng Dong; Ce Zhang; Boxin Xue; Qingyu Wu
Journal:  Clin Sci (Lond)       Date:  2016-06-24       Impact factor: 6.124

4.  Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Maria Chiara Sghirlanzoni; Elena Gagliardini; Sara Conti; Flavio Gaspari; Gianfranco Marchetti; Mauro Abbate; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-06       Impact factor: 8.237

5.  The therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trial.

Authors:  Motoko Kanzaki; Jun Wada; Yoko Kikumoto; Shigeru Akagi; Kazushi Nakao; Hitoshi Sugiyama; Hirofumi Makino
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-06-05

Review 6.  Human albumin infusion for treating oedema in people with nephrotic syndrome.

Authors:  Jacqueline J Ho; Azreen S Adnan; Yee Cheng Kueh; Nurul Jannah Ambak; Hans Van Rostenberghe; Fauziah Jummaat
Journal:  Cochrane Database Syst Rev       Date:  2019-07-12

Review 7.  Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome.

Authors:  Ahmed Hassaan Qavi; Rida Kamal; Robert W Schrier
Journal:  Int J Nephrol       Date:  2015-07-29

Review 8.  Nephrotic Syndrome: Oedema Formation and Its Treatment With Diuretics.

Authors:  Sanjana Gupta; Ruth J Pepper; Neil Ashman; Stephen B Walsh
Journal:  Front Physiol       Date:  2019-01-15       Impact factor: 4.566

Review 9.  Pathophysiology, Evaluation, and Management of Edema in Childhood Nephrotic Syndrome.

Authors:  Demetrius Ellis
Journal:  Front Pediatr       Date:  2016-01-11       Impact factor: 3.418

10.  Acute Kidney Injury Associated with Minimal Change Nephrotic Syndrome in an Elderly Patient Successfully Treated with both Fluid Management and Specific Therapy Based on Kidney Biopsy Findings.

Authors:  Yuko Oyama; Yoichi Iwafuchi; Tetsuo Morioka; Ichiei Narita
Journal:  Case Rep Nephrol Dial       Date:  2020-04-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.